N-methyl-D-aspartate (NMDA) encephalitis

Specialty: Neurology


IVIG is an option for treatment of patients with NMDA. Diagnosis of NMDA requires expert consultation.

IVIG is used in conjunction with immunosuppressive medications and/or plasmapheresis.


Initial dose: Total dose of 2 g/kg divided over 2 to 5 days in adults and children.

Maintenance dose may be considered depending on response to treatment.